Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017

Shanley Smith; Hande Harmanci; Yvan Hutin; Sarah  Hess; Marc Bulterys; Raquel Peck; Bharat Rewari; Antons Mozalevskis; Messeret  Shibeshi; Mutale Mumba; Linh-Vi Le; Naoko Ishikawa; Désiré  Nolna; Leandro Sereno; Charles Gore; David Goldberg; Sharon Hutchinson

doi:10.1016/j.jhepr.2019.04.002

Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017

Shanley Smith, Hande Harmanci, Yvan Hutin, Sarah Hess, Marc Bulterys, Raquel Peck, Bharat Rewari, Antons Mozalevskis, Messeret Shibeshi, Mutale Mumba, Linh-Vi Le, Naoko Ishikawa, Désiré Nolna, Leandro Sereno, Charles Gore, David Goldberg, Sharon Hutchinson

SHLS School Office

Research output: Contribution to journal › Article

75 Downloads (Pure)

Abstract

Background & Aims In 2016, the World Health Assembly passed a resolution to eliminate viral hepatitis as a public health threat by 2030. We aimed to examine the status of the global viral hepatitis response. Methods In 2017, the World Health Organization (WHO) asked the Ministries of Health in all 194 Member States to complete a Country Profile on Viral Hepatitis policy uptake indicators, covering national plans/funding, engagement of civil society, testing guidance, access to treatment, and strategic information. Results Of 194 Member States, 135 (70%) responded, accounting for 87% of the global population infected with hepatitis B virus (HBV) and/or C virus (HCV). Of those responding, 84 (62%) had developed a national plan, of which, 49 (58%) had dedicated funding, and 62 (46%) had engaged with civil society; those engaged with civil society were more likely to have a funded plan than others (52% vs. 23%, p = 0.001). Guidance on testing pregnant women (for HBV) and people who inject drugs (for HCV) was available in 70% and 46% of Member States, respectively; 59% and 38% of Member States reported universal access to optimal therapies for HBV and HCV, respectively. Conclusions Most people living with hepatitis B and C reside in a country with a national hepatitis strategy. Governments who engaged with civil society were more advanced in their response. Member States need to finance these national strategies and ensure that those affected have access to hepatitis services as part of efforts to achieve universal health coverage.

Original language	English
Pages (from-to)	81-89
Number of pages	9
Journal	JHEP Reports
Volume	1
Issue number	2
Early online date	10 May 2019
DOIs	https://doi.org/10.1016/j.jhepr.2019.04.002
Publication status	Published - Aug 2019

Documents and Links

10.1016/j.jhepr.2019.04.002

Smith, S. et al (2019) Global progress on the eliminiation of viral hepatitis as a major public health threat_an analysis of WHO Member State responses 2017
© 2019 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Final published version, 1.23 MBLicence: CC BY-NC-ND

Fingerprint Dive into the research topics of 'Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017'. Together they form a unique fingerprint.

Cite this

Smith, S., Harmanci, H., Hutin, Y., Hess, S., Bulterys, M., Peck, R., Rewari, B., Mozalevskis, A., Shibeshi, M., Mumba, M., Le, L-V., Ishikawa, N., Nolna, D., Sereno, L., Gore, C., Goldberg, D., & Hutchinson, S. (2019). Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017. JHEP Reports, 1(2), 81-89. https://doi.org/10.1016/j.jhepr.2019.04.002

Smith, Shanley ; Harmanci, Hande ; Hutin, Yvan ; Hess, Sarah ; Bulterys, Marc ; Peck, Raquel ; Rewari, Bharat ; Mozalevskis, Antons ; Shibeshi, Messeret ; Mumba, Mutale ; Le, Linh-Vi ; Ishikawa, Naoko ; Nolna, Désiré ; Sereno, Leandro ; Gore, Charles ; Goldberg, David ; Hutchinson, Sharon. / Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017. In: JHEP Reports. 2019 ; Vol. 1, No. 2. pp. 81-89.

@article{d930005460754c4d9f659f16fc0eb27e,

title = "Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017",

abstract = "Background & Aims In 2016, the World Health Assembly passed a resolution to eliminate viral hepatitis as a public health threat by 2030. We aimed to examine the status of the global viral hepatitis response. Methods In 2017, the World Health Organization (WHO) asked the Ministries of Health in all 194 Member States to complete a Country Profile on Viral Hepatitis policy uptake indicators, covering national plans/funding, engagement of civil society, testing guidance, access to treatment, and strategic information. Results Of 194 Member States, 135 (70%) responded, accounting for 87% of the global population infected with hepatitis B virus (HBV) and/or C virus (HCV). Of those responding, 84 (62%) had developed a national plan, of which, 49 (58%) had dedicated funding, and 62 (46%) had engaged with civil society; those engaged with civil society were more likely to have a funded plan than others (52% vs. 23%, p = 0.001). Guidance on testing pregnant women (for HBV) and people who inject drugs (for HCV) was available in 70% and 46% of Member States, respectively; 59% and 38% of Member States reported universal access to optimal therapies for HBV and HCV, respectively. Conclusions Most people living with hepatitis B and C reside in a country with a national hepatitis strategy. Governments who engaged with civil society were more advanced in their response. Member States need to finance these national strategies and ensure that those affected have access to hepatitis services as part of efforts to achieve universal health coverage.",

author = "Shanley Smith and Hande Harmanci and Yvan Hutin and Sarah Hess and Marc Bulterys and Raquel Peck and Bharat Rewari and Antons Mozalevskis and Messeret Shibeshi and Mutale Mumba and Linh-Vi Le and Naoko Ishikawa and D{\'e}sir{\'e} Nolna and Leandro Sereno and Charles Gore and David Goldberg and Sharon Hutchinson",

note = "Acceptance from webpage OA article ",

year = "2019",

month = aug,

doi = "10.1016/j.jhepr.2019.04.002",

language = "English",

volume = "1",

pages = "81--89",

journal = "JHEP Reports",

issn = "2589-5559",

number = "2",

}

Smith, S, Harmanci, H, Hutin, Y, Hess, S, Bulterys, M, Peck, R, Rewari, B, Mozalevskis, A, Shibeshi, M, Mumba, M, Le, L-V, Ishikawa, N, Nolna, D, Sereno, L, Gore, C, Goldberg, D & Hutchinson, S 2019, 'Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017', JHEP Reports, vol. 1, no. 2, pp. 81-89. https://doi.org/10.1016/j.jhepr.2019.04.002

Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017. / Smith, Shanley; Harmanci, Hande; Hutin, Yvan; Hess, Sarah ; Bulterys, Marc; Peck, Raquel; Rewari, Bharat; Mozalevskis, Antons; Shibeshi, Messeret ; Mumba, Mutale; Le, Linh-Vi; Ishikawa, Naoko; Nolna, Désiré ; Sereno, Leandro; Gore, Charles; Goldberg, David; Hutchinson, Sharon.

In: JHEP Reports, Vol. 1, No. 2, 08.2019, p. 81-89.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017

AU - Smith, Shanley

AU - Harmanci, Hande

AU - Hutin, Yvan

AU - Hess, Sarah

AU - Bulterys, Marc

AU - Peck, Raquel

AU - Rewari, Bharat

AU - Mozalevskis, Antons

AU - Shibeshi, Messeret

AU - Mumba, Mutale

AU - Le, Linh-Vi

AU - Ishikawa, Naoko

AU - Nolna, Désiré

AU - Sereno, Leandro

AU - Gore, Charles

AU - Goldberg, David

AU - Hutchinson, Sharon

N1 - Acceptance from webpage OA article

PY - 2019/8

Y1 - 2019/8

N2 - Background & Aims In 2016, the World Health Assembly passed a resolution to eliminate viral hepatitis as a public health threat by 2030. We aimed to examine the status of the global viral hepatitis response. Methods In 2017, the World Health Organization (WHO) asked the Ministries of Health in all 194 Member States to complete a Country Profile on Viral Hepatitis policy uptake indicators, covering national plans/funding, engagement of civil society, testing guidance, access to treatment, and strategic information. Results Of 194 Member States, 135 (70%) responded, accounting for 87% of the global population infected with hepatitis B virus (HBV) and/or C virus (HCV). Of those responding, 84 (62%) had developed a national plan, of which, 49 (58%) had dedicated funding, and 62 (46%) had engaged with civil society; those engaged with civil society were more likely to have a funded plan than others (52% vs. 23%, p = 0.001). Guidance on testing pregnant women (for HBV) and people who inject drugs (for HCV) was available in 70% and 46% of Member States, respectively; 59% and 38% of Member States reported universal access to optimal therapies for HBV and HCV, respectively. Conclusions Most people living with hepatitis B and C reside in a country with a national hepatitis strategy. Governments who engaged with civil society were more advanced in their response. Member States need to finance these national strategies and ensure that those affected have access to hepatitis services as part of efforts to achieve universal health coverage.

AB - Background & Aims In 2016, the World Health Assembly passed a resolution to eliminate viral hepatitis as a public health threat by 2030. We aimed to examine the status of the global viral hepatitis response. Methods In 2017, the World Health Organization (WHO) asked the Ministries of Health in all 194 Member States to complete a Country Profile on Viral Hepatitis policy uptake indicators, covering national plans/funding, engagement of civil society, testing guidance, access to treatment, and strategic information. Results Of 194 Member States, 135 (70%) responded, accounting for 87% of the global population infected with hepatitis B virus (HBV) and/or C virus (HCV). Of those responding, 84 (62%) had developed a national plan, of which, 49 (58%) had dedicated funding, and 62 (46%) had engaged with civil society; those engaged with civil society were more likely to have a funded plan than others (52% vs. 23%, p = 0.001). Guidance on testing pregnant women (for HBV) and people who inject drugs (for HCV) was available in 70% and 46% of Member States, respectively; 59% and 38% of Member States reported universal access to optimal therapies for HBV and HCV, respectively. Conclusions Most people living with hepatitis B and C reside in a country with a national hepatitis strategy. Governments who engaged with civil society were more advanced in their response. Member States need to finance these national strategies and ensure that those affected have access to hepatitis services as part of efforts to achieve universal health coverage.

U2 - 10.1016/j.jhepr.2019.04.002

DO - 10.1016/j.jhepr.2019.04.002

M3 - Article

VL - 1

SP - 81

EP - 89

JO - JHEP Reports

JF - JHEP Reports

SN - 2589-5559

IS - 2

ER -